Hyaluronic acid-ethylenediamine-cinnamic acid attenuates IBS-D via regulating 5-hydroxytryptamine signaling pathway, intestinal barrier and gut microbiota.

Cui, Li et al.·International journal of biological macromolecules·2026·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Hyaluronic acid-ethylenediamine-cinnamic acid attenuates IBS-D via regulating 5-hydroxytryptamine signaling pathway, intestinal barrier and gut microbiota.
Published In:: International journal of biological macromolecules, 348, 150694 (2026)
Authors:: Cui, Li, Zhong, Rongling, Peng, Wanqiu, Zhang, Zhenhai, An, Zhentao, Li, Hui
Database ID:: RPEP-15060

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-15060·https://rethinkpeptides.com/research/RPEP-15060

APA

Cui, Li; Zhong, Rongling; Peng, Wanqiu; Zhang, Zhenhai; An, Zhentao; Li, Hui. (2026). Hyaluronic acid-ethylenediamine-cinnamic acid attenuates IBS-D via regulating 5-hydroxytryptamine signaling pathway, intestinal barrier and gut microbiota.. International journal of biological macromolecules, 348, 150694. https://doi.org/10.1016/j.ijbiomac.2026.150694

MLA

Cui, Li, et al. "Hyaluronic acid-ethylenediamine-cinnamic acid attenuates IBS-D via regulating 5-hydroxytryptamine signaling pathway, intestinal barrier and gut microbiota.." International journal of biological macromolecules, 2026. https://doi.org/10.1016/j.ijbiomac.2026.150694

RethinkPeptides

RethinkPeptides Research Database. "Hyaluronic acid-ethylenediamine-cinnamic acid attenuates IBS..." RPEP-15060. Retrieved from https://rethinkpeptides.com/research/cui-2026-hyaluronic-acidethylenediaminecinnamic-acid-attenuates

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database